Skip to main content
ABUS logo

ABUS · Arbutus Biopharma Corp · Held by Funds

Track ABUS — free
$4.02 -0.05 (-1.23%) At close · Nov 20 Q3 2024 earnings call transcript
Market Cap
$616.24M
Shares
153.29M
Volume · Nov 20 2.99M Avg daily vol (3M) 5.19M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of ABUS by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 17.66% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 3.41% 5,232,742
Index ETFs 14.25% 21,844,809
Active ETFs 0.20% 312,784
Active funds 4.38% 6,708,828
Unclassified 0.00% 6,566
All registered funds 22.25% 34,105,729
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding ABUS

144 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 144 positions
Key facts CIK 1447028 CUSIP 03879J100 13F (30d) 221 filings 200 filers Visit website Investor relations